A CNS discovers that a landmark RCT supporting a unit protocol was funded entirely by the manufacturer of the intervention device. Which threat to evidence quality should PRIMARILY be considered?
-
A
Potential industry funding bias affecting outcome reporting
-
B
Lack of external validity
-
C
Inadequate blinding of participants
-
D
Insufficient follow-up duration